156 related articles for article (PubMed ID: 8849251)
1. Frequency of drug resistance in Plasmodium falciparum: a nonsynergistic combination of 5-fluoroorotate and atovaquone suppresses in vitro resistance.
Gassis S; Rathod PK
Antimicrob Agents Chemother; 1996 Apr; 40(4):914-9. PubMed ID: 8849251
[TBL] [Abstract][Full Text] [Related]
2. Variations in frequencies of drug resistance in Plasmodium falciparum.
Rathod PK; McErlean T; Lee PC
Proc Natl Acad Sci U S A; 1997 Aug; 94(17):9389-93. PubMed ID: 9256492
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic effects of inhibitors of de novo pyrimidine biosynthesis upon Plasmodium falciparum.
Seymour KK; Lyons SD; Phillips L; Rieckmann KH; Christopherson RI
Biochemistry; 1994 May; 33(17):5268-74. PubMed ID: 7909690
[TBL] [Abstract][Full Text] [Related]
4. Selective activity of 5-fluoroorotic acid against Plasmodium falciparum in vitro.
Rathod PK; Khatri A; Hubbert T; Milhous WK
Antimicrob Agents Chemother; 1989 Jul; 33(7):1090-4. PubMed ID: 2675756
[TBL] [Abstract][Full Text] [Related]
5. Biguanide-atovaquone synergy against Plasmodium falciparum in vitro.
Jones K; Ward SA
Antimicrob Agents Chemother; 2002 Aug; 46(8):2700-3. PubMed ID: 12121961
[TBL] [Abstract][Full Text] [Related]
6. Modified fixed-ratio isobologram method for studying in vitro interactions between atovaquone and proguanil or dihydroartemisinin against drug-resistant strains of Plasmodium falciparum.
Fivelman QL; Adagu IS; Warhurst DC
Antimicrob Agents Chemother; 2004 Nov; 48(11):4097-102. PubMed ID: 15504827
[TBL] [Abstract][Full Text] [Related]
7. dCTP levels are maintained in Plasmodium falciparum subjected to pyrimidine deficiency or excess.
Seymour KK; Yeo AE; Rieckmann KH; Christopherson RI
Ann Trop Med Parasitol; 1997 Sep; 91(6):603-9. PubMed ID: 9425362
[TBL] [Abstract][Full Text] [Related]
8. Multiple synergistic interactions between atovaquone and antifolates against Plasmodium falciparum in vitro: a rational basis for combination therapy.
Nduati EW; Kamau EM
Acta Trop; 2006 Mar; 97(3):357-63. PubMed ID: 16457769
[TBL] [Abstract][Full Text] [Related]
9. Pharmacodynamic interactions among atovaquone, proguanil and cycloguanil against Plasmodium falciparum in vitro.
Thapar MM; Gupta S; Spindler C; Wernsdorfer WH; Björkman A
Trans R Soc Trop Med Hyg; 2003; 97(3):331-7. PubMed ID: 15228254
[TBL] [Abstract][Full Text] [Related]
10. Molecular targets of 5-fluoroorotate in the human malaria parasite, Plasmodium falciparum.
Rathod PK; Leffers NP; Young RD
Antimicrob Agents Chemother; 1992 Apr; 36(4):704-11. PubMed ID: 1503432
[TBL] [Abstract][Full Text] [Related]
11. Effects of dual combinations of antifolates with atovaquone or dapsone on nucleotide levels in Plasmodium falciparum.
Yeo AE; Seymour KK; Rieckmann KH; Christopherson RI
Biochem Pharmacol; 1997 Apr; 53(7):943-50. PubMed ID: 9174107
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of atovaquone against the African isolates and clones of Plasmodium falciparum.
Basco LK; Ramiliarisoa O; Le Bras J
Am J Trop Med Hyg; 1995 Oct; 53(4):388-91. PubMed ID: 7485692
[TBL] [Abstract][Full Text] [Related]
13. Molecular epidemiology of malaria in Cameroon. XVII. Baseline monitoring of atovaquone-resistant Plasmodium falciparum by in vitro drug assays and cytochrome b gene sequence analysis.
Basco LK
Am J Trop Med Hyg; 2003 Aug; 69(2):179-83. PubMed ID: 14506774
[TBL] [Abstract][Full Text] [Related]
14. Interactions of atovaquone with other antimalarial drugs against Plasmodium falciparum in vitro.
Canfield CJ; Pudney M; Gutteridge WE
Exp Parasitol; 1995 May; 80(3):373-81. PubMed ID: 7729473
[TBL] [Abstract][Full Text] [Related]
15. In vitro recrudescence of Plasmodium falciparum parasites suppressed to dormant state by atovaquone alone and in combination with proguanil.
Thapar MM; Gil JP; Björkman A
Trans R Soc Trop Med Hyg; 2005 Jan; 99(1):62-70. PubMed ID: 15550263
[TBL] [Abstract][Full Text] [Related]
16. Potentiation of the antimalarial activity of atovaquone by doxycycline against Plasmodium falciparum in vitro.
Yeo AE; Edstein MD; Shanks GD; Rieckmann KH
Parasitol Res; 1997; 83(5):489-91. PubMed ID: 9197398
[TBL] [Abstract][Full Text] [Related]
17. Antimalarial activity of a combination of 5-fluoroorotate and uridine in mice.
Gómez ZM; Rathod PK
Antimicrob Agents Chemother; 1990 Jul; 34(7):1371-5. PubMed ID: 2386369
[TBL] [Abstract][Full Text] [Related]
18. [What is the value of the combination atovaquone-proguanil for the clinician?].
Delmont J
Med Trop (Mars); 2002; 62(3):232-6. PubMed ID: 12244917
[TBL] [Abstract][Full Text] [Related]
19. The activity of triple combinations of antifolate biguanides, with and without folinic acid, against plasmodium falciparum in vitro.
Yeo AE; Rieckmann KH
Ann Trop Med Parasitol; 1997 Apr; 91(3):247-51. PubMed ID: 9229018
[TBL] [Abstract][Full Text] [Related]
20. Short communication: Prevalence of mutations associated with resistance to atovaquone and to the antifolate effect of proguanil in Plasmodium falciparum isolates from northern Ghana.
Muehlen M; Schreiber J; Ehrhardt S; Otchwemah R; Jelinek T; Bienzle U; Mockenhaupt FP
Trop Med Int Health; 2004 Mar; 9(3):361-3. PubMed ID: 14996365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
